AIM
TEVA icon

Allstate Investment Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Allstate Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$101K Buy
+11,105
New +$96.9K ﹤0.01% 577

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Allstate Investment Management's TEVA Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q4 2022: 11,105 shares worth $101K. The stake represents ﹤0.01% of the portfolio and ranks #577 among its holdings.

421 funds tracked by Wall St. Rank hold TEVA as of Q4 2022.

  • Allstate Investment Management held 11,105 shares of Teva Pharmaceutical Industries Limited worth $101K as of Q4 2022.
  • Teva Pharmaceutical Industries Limited was a new Allstate Investment Management position in Q4 2022.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Allstate Investment Management's portfolio in Q4 2022, its #577 holding.
  • 421 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.